Amphastar Pharmaceuticals (AMPH)
(Delayed Data from NSDQ)
$47.57 USD
+1.28 (2.77%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $47.56 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth D Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$47.57 USD
+1.28 (2.77%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $47.56 -0.01 (-0.02%) 7:58 PM ET
3-Hold of 5 3
A Value B Growth D Momentum B VGM
Zacks News
Amphastar Pharmaceuticals (AMPH) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Amphastar (AMPH) delivered earnings and revenue surprises of 166.67% and 4.26%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Amphastar Pharmaceuticals (AMPH) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Amphastar (AMPH) delivered earnings and revenue surprises of 233.33% and 6.36%, respectively, for the quarter ended March 2019. Do the numbers hold clues to what lies ahead for the stock?
Amphastar Pharmaceuticals (AMPH) to Report Q1 Results: Wall Street Expects Earnings Growth
by Zacks Equity Research
Amphastar (AMPH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MNK or AMPH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MNK vs. AMPH: Which Stock Is the Better Value Option?
MNK vs. AMPH: Which Stock Is the Better Value Option?
by Zacks Equity Research
MNK vs. AMPH: Which Stock Is the Better Value Option?
MNK vs. AMPH: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
MNK vs. AMPH: Which Stock Is the Better Value Option?
Amphastar Pharmaceuticals (AMPH) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Amphastar (AMPH) delivered earnings and revenue surprises of 30.00% and 18.85%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
MNK vs. AMPH: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
MNK vs. AMPH: Which Stock Is the Better Value Option?
MNK vs. AMPH: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
MNK vs. AMPH: Which Stock Is the Better Value Option?
MNK vs. AMPH: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
MNK vs. AMPH: Which Stock Is the Better Value Option?
MNK vs. AMPH: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
MNK vs. AMPH: Which Stock Is the Better Value Option?
BHC vs. AMPH: Which Stock Is the Better Value Option?
by Zacks Equity Research
BHC vs. AMPH: Which Stock Is the Better Value Option?
Amphastar Pharmaceuticals (AMPH) Catches Eye: Stock Jumps 6.7%
by Zacks Equity Research
Amphastar Pharmaceuticals (AMPH) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
BHC or AMPH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
BHC vs. AMPH: Which Stock Is the Better Value Option?
Amphastar Pharmaceuticals (AMPH) Matches Q3 Earnings Estimates
by Zacks Equity Research
Amphastar (AMPH) delivered earnings and revenue surprises of 0.00% and 1.37%, respectively, for the quarter ended September 2018. Do the numbers hold clues to what lies ahead for the stock?
MNK or AMPH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MNK vs. AMPH: Which Stock Is the Better Value Option?
MNK or AMPH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MNK vs. AMPH: Which Stock Is the Better Value Option?
AKRX vs. AMPH: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
AKRX vs. AMPH: Which Stock Is the Better Value Option?
AKRX vs. AMPH: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
AKRX vs. AMPH: Which Stock Is the Better Value Option?
MNK vs. AMPH: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
MNK vs. AMPH: Which Stock Is the Better Value Option?
Amphastar Pharmaceuticals (AMPH) Misses Q2 Earnings Estimates
by Zacks Equity Research
Amphastar (AMPH) delivered earnings and revenue surprises of -62.50% and 10.87%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
AGN vs. AMPH: Which Stock Is the Better Value Option?
by Zacks Equity Research
AGN vs. AMPH: Which Stock Is the Better Value Option?
New Strong Sell Stocks for June 14th
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:
Moving Average Crossover Alert: Amphastar Pharmaceuticals, Inc. (AMPH)
by Zacks Equity Research
Moving Average Crossover Alert: Amphastar Pharmaceuticals, Inc. (AMPH)
New Strong Sell Stocks for June 1st
by Zacks Equity Research
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today: